How counties can extend the reach of drug disposal programs with at-home drug deactivation and disposal
Upcoming Events
Related News

From our PartnersThis blog post is sponsored by NACo partner Deterra. Empower Your Community: Enhance Drug Disposal Programs with At-Home Deactivation & Disposal Solutions |
Now is a critical time for counties to engage their communities in the prevention of drug misuse. It’s an important topic year-round, but several upcoming milestones provide key rallying moments that counties can capitalize on to promote local prevention efforts:
- National Prevention Week (May 7-13)
- Fentanyl Awareness Day (May 9)
- International Overdose Awareness Day (August 31)
- National Night Out (August 1)
- National Recovery Month (September)
- Youth Substance Use Prevention Month (October)
- National Prescription Drug Take Back Day (October and April)
- Red Ribbon Week (October 23-31)
- Holiday Season (November-December)
Local government and public safety agencies can use these opportunities to encourage proper disposal of unwanted and expired medications to help prevent misuse, theft and overdoses. Plus, it’s a great chance to engage with your community through your social media channels and local media outlets. Check out our Outreach Toolkit for sample social media content, newsletter blurbs and media outreach templates.
The Deterra® Drug Deactivation and Disposal System, an at-home medication disposal system, can help extend the reach of disposal efforts by empowering community members to promptly dispose of unwanted drugs as soon as they are no longer needed. Deterra safely destroys prescription and over-the-counter medications as well as fentanyl and virtually all illicit drugs.
Tips for executing a successful drug deactivation and disposal campaign
Mail drug deactivation and disposal pouches to local households. A bulk mailing of drug deactivation and disposal pouches is an impactful way to get these tools into the community and help households clean out their medicine cabinets. Plus, it’s cost-effective: the cost of mailing is offset by significant savings on the administrative costs involved in other distribution strategies.
- Deterra offers direct-to-household mailing services as well as educational postcards, labels and surveys that can be customized with your organization’s information through its Value Added Services.
- Distribute resources at events. Deterra is a perfect complement to take-back days and prevention events, but don’t limit yourself to just these. You can reach an even broader audience at events like:
- County fairs
- National Night Out get-togethers
- Food drives
- Naloxone trainings
- Community festivals
- Include in overdose prevention kits. Putting together resource kits is a great way to get multiple tools into peoples’ hands. If your team is already distributing other prevention resources like naloxone or medication storage boxes, adding a Deterra Pouch and information on proper drug disposal is easy.
Funding opportunities for proper at-home drug disposal
As an evidence-based prevention solution, Deterra is an eligible expense for opioid settlement dollars and many federal and state grant opportunities. If your county has allocation plans in place for opioid settlement money, funds designated for prevention activities can support the purchase and distribution of Deterra. If your county is in the planning stage, the Deterra team can help you build at-home drug deactivation and disposal into your plans.
Use our updated funding directory to find additional funding options and download the newly expanded Deterra Grant Guide for practical grant-writing tips to help you add at-home drug deactivation and disposal to your prevention efforts.
Post Sponsor

Related News

CMS announces grant awards to improve the continuity of care for justice-involved individuals
On September 27, the Centers for Medicare & Medicaid Services announced $106.5 million in state planning grants aimed at improving healthcare continuity for individuals transitioning from incarceration.

SAMHSA releases new 2024 data on rates of mental illness and substance use disorder in the U.S.
On July 28, the U.S. Department of Health and Human Services’ (HHS) Substance Abuse and Mental Health Services Administration (SAMHSA) released the findings of its annual National Survey on Drug Use and Health (NSDUH), which provides data on rates of substance use and mental illness at the national, state and local level.

HALT Fentanyl Act signed into law
On July 16, the Halt All Lethal Trafficking of Fentanyl Act (HALT Fentanyl Act) (P.L. 119-26) was signed into law, marking a major turning point in the nation’s response to the opioid epidemic. The bipartisan legislation permanently classifies fentanyl-related substances (FRS) as Schedule I drugs under the Controlled Substances Act, granting law enforcement the authority to combat the growing threat posed by synthetic opioids. The law’s enactment follows years of temporary extensions that placed these substances under federal control on a provisional basis.